Chronic obstructive pulmonary disease is missed in asthmatics in specialty care in Trinidad, West Indies

International Journal of Tuberculosis and Lung Disease

Volumn 11, Issue 9, 2007, Pages 1026-1032

  Pinto Pereira, Lexley M ^a   Bartholomew, L A ^a   Brooks, H ^a   Lowe, D ^a   Rocke, K ^a   Rolle, S ^a   Smith, J ^a   Thekwini, O ^a   Seemungal, T A R ^a   Bekele, I ^a  

^a UNIVERSITY OF THE WEST INDIES   (Trinidad and Tobago)

Author keywords

Asthma; COPD; Lung function; Sex; Smoking

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; IPRATROPIUM BROMIDE; THEOPHYLLINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC ERROR; EARLY DIAGNOSIS; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RESPIRATORY CARE; SCREENING TEST; SEX RATIO; SMOKING; SPIROMETRY; TREATMENT RESPONSE; TRINIDAD AND TOBAGO;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASTHMA; CROSS-SECTIONAL STUDIES; DIAGNOSTIC ERRORS; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; RISK FACTORS; SMOKING; TRINIDAD AND TOBAGO;

EID: 34548773430     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Jeffrey P K. Remodelling in asthma and chronic obstructive lung disease. Am J Respir Crit Care Med 2001; 164 (Suppl): S28-S39.
2. Kaminsky D A, Marcy T W, Bachand M, Irvin C G. Knowledge and use of office spirometry for the detection of chronic obstructive pulmonary disease by primary care physicians. Respir Care 2005; 50: 1639-1648.
3. Kesten S, Chapman K R. Physician perceptions and management of COPD. Chest 1993; 104: 254-258.
4. Chapman K R, Tashkin D P, Pye D J. Gender bias in the diagnosis of COPD. Chest 2001; 119: 1691-1695.
5. Mannino D M, Homa D M, Akinbami L J, Ford E S, Redd S C. Chronic obstructive pulmonary disease surveillance - United States, 1971-2000. MMWR Surveill Summ 2002; 51: 1-16.
6. Weiss S T, DeMeo D L, Postma D S. COPD: problems in diagnosis and measurement. Eur Respir J 2003; 41 (Suppl): S4-S12.
7. Hurd S S. International efforts directed at attacking the problem of COPD. Chest 2000; 117 (Suppl): S336-S338.
8. Murray C J, Lopez A D. Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet 1997; 349: 1498-1504.
9. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. National Heart, Lung and Blood Institute/World Health Organization workshop report. NIH publication report no. 2701. Bethesda, MD, USA: National Heart, Lung and Blood Institute, 2006.
10. Caramori G, Bettoncelli G, Tosatto R, et al. Underuse of spirometry by general practitioners for the diagnosis of COPD in Italy. Monaldi Arch Chest Dis 2005; 63: 6-12.
11. van den Boom G, Rutten-van Molken M P, Molema J, Tirimanna P R, van Weel C, van Schayck C P. Association between health-related quality of life and consultation for respiratory symptoms: results from the DIMCA programme. Eur Respir J 1998; 11: 67-72.
12. Mohammed F, Bootoor S, Panday A, et al. Predictors of repeat visits to the emergency room by asthmatic children in primary care. J Natl Med Assoc 2006; 98: 1278-1285.
13. Monteil M A, Joseph G, Changkit C, Wheeler G, Antoine R M. Comparison of prevalence and severity of asthma among adolescents in the Caribbean islands of Trinidad and Tobago: results of a nationwide cross-sectional survey. BMC Public Health 2005; 5: 96.
14. Mahabir D, Pooran S, Motilal H, Ishmael M, Hinds N, Gulliford M C. Acute severe asthma in Trinidad and Tobago. Int J Tuberc Lung Dis 1999; 3: 198-201.
15. Pinto-Pereira L M, Clement Y, Da Silva C K, McIntosh D, Simeon D T. Understanding and use of inhaler medication by asthmatics in specialty care in Trinidad: a study following development of Caribbean guidelines for asthma management and prevention. Chest 2002; 121: 1833-1840.
16. Larsen R J, Marx M L. An introduction to mathematical statistics and its application. 2nd ed. Englewood Cliffs, NJ, USA: Prentice Hall, 1986.
17. Celli B R, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23: 932-948.
18. Francis B, Green M, Payne C. The GLIM System release 4 manual. Oxford, UK: Clarendon Press, 1994.
19. Pauwels R A, Rabe K F. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet. 2004; 364: 613-620.
20. Tinkelman D G, Price D B, Nordyke R J, Halbert R J. Misdiagnosis of COPD and asthma in primary care patients 40 years of age and over. J Asthma 2006; 45: 75-80.
21. Griffiths C, Feder G, Wedzicha J, Foster G, Livingstone A, Marlowe G S. Feasibility of spirometry and reversibility testing for the identification of patients with chronic obstructive pulmonary disease on asthma registers in general practice. Respir Med 1999; 93: 903-908.
22. Burrows B, Bloom J W, Traver G A, Cline M G. The course and prognosis of different forms of chronic airways obstruction in a sample from the general population. N Engl J Med 1987; 317: 1309-1314.
23. de Marco R, Accordini S, Cerveri I, et al. An international survey of chronic obstructive pulmonary disease in young adults according to GOLD stages. Thorax 2004; 59: 120-125.
24. Mannino D M. COPD Epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. Chest 2002; 121 (Suppl): S121-S126.
25. Dompeling E, van Schayck C P, Molema J, et al. A comparison of six different ways of expressing the bronchodilating response in asthma and COPD; reproducibility and dependence of prebronchodilator FEV1. Eur Respir J 1992; 5: 975-981.
26. Van Schayck C P, Loozen J M, Wagena E, Akkermans R P, Wesseling G J. Detecting patients at a high risk of developing chronic obstructive pulmonary disease in general practice: cross-sectional case finding study. BMJ 2002; 324: 1570.
27. Anthonisen N R, Dik N, Manfreda J, Roos L L. Spirometry and obstructive lung disease. Manitoba Can Respir J 2001; 8: 421-426.
28. Siafakis N M, Vermeire P, Pride N B, et al. ERS - consensus statement. Optimal assessment and management of chronic obstructive pulmonarv disease (COPD). Eur Respir J 1995; 8: 1398-1420.
29. Eisner M D, Balmes J, Yelin E H, et al. Directly measured secondhand smoke exposure and COPD health outcomes. BMC Pulm Med 2006; 6: 12.
30. Tsai C L, Clark S, Cydulka R K, Rowe B H, Carmargo C A Jr. Factors associated with hospital admission among emergency department patients with chronic obstructive pulmonary disease exacerbation. Acad Emerg Med 2007; 14: 6-14.
31. de Torres J P, Casanova C, Hernandez C, Abreu J, Aguirre-Jaime A, Celli B R. Gender and COPD in patients attending a pulmonary clinic. Chest 2005; 128: 2012-2016.
32. Gan W Q, Man S F, Postma D S, Camp P, Sin D D. Female smokers beyond the perimenopausal period are at increased risk of chronic obstructive pulmonary disease: a systematic review and meta-analvsis. Respir Res 2006; 7: 52.
33. ZuWallack A R, ZuWallack R L. Tiotropium bromide, a new, once-daily inhaled anticholinergic bronchodilator for chronic-obstructive pulmonary disease. Expert Opin Pharmacother 2004; 5: 1827-1835.
34. Sin D D, McAlister F A, Man S F, Anthonisen N R. Contemporary management of chronic obstructive pulmonary disease: scientific review. JAMA 2005; 290: 2301-2312.
35. Wedzicha J A, Seemungal T A R. Inhaled corticosteroids in COPD: a light at the end of the tunnel? Thorax 2005; 60: 977-978.